About this item:

309 Views | 447 Downloads

Author Notes:

Corresponding author: Hubert Department of Global Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE Room 6007, Atlanta, GA 30322, USA. Tel: +404-712-8675; Fax: +404-712-8969; E–mail: jvidalg@emory.edu

Authors are thankful to Dr Lesley McGee and Dr Bernard Beall from the CDC for providing several pneumococcal serotypes and all other streptococci utilized in this study.

We also want to thank Dr Catherine Satzke, Dr Eileen Dunne and Professor Kim Mulholland, from Murdoch Childrens Research Institute, for stimulating discussion and providing support and advice to develop new technology for pneumococcal serotyping.

Conflict of interest. None declared.

Subjects:

Research Funding:

This work was supported by a subcontract granted to JEV (No. 26180) by Murdoch Childrens Research Institute, which received funds from the Bill and Melinda Gates Foundation (Grant 52099).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Microbiology
  • Streptococcus pneumoniae
  • serotype
  • qPCR
  • NUversa
  • STREPTOCOCCUS-PNEUMONIAE
  • CONJUGATE VACCINE
  • DISEASE
  • PCR
  • CHILDREN
  • COVERAGE
  • BURDEN
  • ASSAYS

Development and characterization of a synthetic DNA, NUversa, to be used as a standard in quantitative polymerase chain reactions for molecular pneumococcal serotyping

Tools:

Journal Title:

FEMS Microbiology Letters

Volume:

Volume 364, Number 17

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Identification of Streptococcus pneumoniae and its more than 90 serotypes is routinely conducted by culture and Quellung reactions. Quantitative polymerase chain reactions (qPCRs) have been developed for molecular detection, including a pan-pneumococcus lytA assay, and assays targeting 79 serotypes. Reactions require genomic DNA from every target to prepare standards, which can be time consuming. In this study, we have developed a synthetic DNA molecule as a surrogate for genomic DNA and present new single-plex qPCR reactions to increase molecular detection to 94 pneumococcal serotypes. Specificity of these new reactions was confirmed with a limit of detection between 2 and 20 genome equivalents/reaction. A synthetic DNA (NUversa, ~8.2 kb) was then engineered to contain all available qPCR targets for serotyping and lytA. NUversa was cloned into pUC57-Amp-modified to generate pNUversa (~10.2 kb). Standards prepared from pNUversa and NUversa were compared against standards made out of genomic DNA. Linearity [NUversa (R 2 > 0.982); pNUversa (R 2 > 0.991)] and efficiency of qPCR reactions were similar to those utilizing chromosomal DNA (R 2 > 0.981). Quantification with plasmid pNUversa was affected, however, whereas quantification with synthetic NUversa was comparable to that of genomic DNA. Therefore, NUversa may be utilized as DNA standard in single-plex assays of the currently known 94 pneumococcal serotypes.

Copyright information:

© FEMS 2017.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote